Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease
Blann, A.D.; Lip, G.Y.; Fijnheer, R.
Circulation 99(18): 2478-2479
1999
ISSN/ISBN: 0009-7322 PMID: 10318743 Document Number: 500675
Document emailed within 1 workday
Related Documents
Mashru, M.R.; Shah, V.K.; Soneji, S.L.; Loya, Y.S.; Vasvani, J.B.; Payannavar, S.; Walvalkar, A.; Mithbawkar, S.S.; Mokal, R.; Kudalkar, K.; Abraham, A.; Thakur, P.K.; Shalia, K.K. 2010: Soluble levels of cell adhesion molecules (CAMs) in coronary artery disease Indian Heart Journal 62(1): 57-63Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Bloom, B.J.; Nelson, S.M.; Eisenberg, D.; Alario, A.J. 2005: Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis Journal of Rheumatology 32(2): 366-372
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Hwang, S.J.; Ballantyne, C.M.; Sharrett, A.R.; Smith, L.C.; Davis, C.E.; Gotto, A.M.; Boerwinkle, E. 1997: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study Circulation 96(12): 4219-4225
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Mizia-Stec, K.; Zahorska-Markiewicz, B.; Goliszek, L. 2003: Adhesion molecules: atherosclerosis and coronary artery disease Przeglad Lekarski 60(3): 147-150
Atalar, E.; Haznedaroğlu, Y.; Aytemir, K.; Ozer, N.; Aksöyek, S.; Ovünç, K.; Kirazly, S.; Ozmen, F. 2000: Circulating adhesion molecules in patients with stable coronary artery disease International Journal of Hematology 72(4): 507-511
Masauzi, N. 1996: Expression of differentiation antigens and adhesion molecules on CD34+ cells in peripheral blood and bone marrow after chemotherapy followed by administration of granulocyte colony stimulating factor Hokkaido Journal of Medical Science 71(6): 771-783
Lehmkuhl, H.; Horn, C.; von der Driesch, P.; Kämmerer, U.; Müller, T.; von der Emde, J.; Olbrich, H.G.; Kunkel, B.; Bachmann, K. 1996: Analysis of adhesion molecules in myocardial biopsies of cardiac allografts and coronary artery disease with CABG Journal of Cardiovascular Surgery 37(6 Suppl 1: 65-70
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Silveira, A.M.; Elgue, G.; Hamsten, A.; Blombäck, M. 1992: von Willebrand factor in plasma and urine of men with premature coronary artery disease Thrombosis and Haemostasis 67(1): 161-165
Proudman, S.M.; Cleland, L.G.; Mayrhofer, G. 1999: Effects of tumor necrosis factor-alpha, interleukin 1beta, and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice Journal of Rheumatology 26(9): 1877-1889
Seigneur, M.; Constans, J.; Blann, A.; Renard, M.; Pellegrin, J.L.; Amiral, J.; Boisseau, M.; Conri, C. 1997: Soluble adhesion molecules and endothelial cell damage in HIV infected patients Thrombosis and Haemostasis 77(4): 646-649
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602
Lu, H-He.; Sheng, Z-Qiang.; Wang, Y.; Zhang, L. 2010: Levels of soluble adhesion molecules in patients with various clinical presentations of coronary atherosclerosis Chinese Medical Journal 123(21): 3123-3126
Kauhanen, P.; Beer, J.H.; Lassila, R. 1997: Defective interaction between von Willebrand factor and platelet glycoprotein Ib--a familial study of peripheral arterial occlusive disease Thrombosis and Haemostasis 77(5): 849-855
Morsy, T.A.; el-Shazly, A.M.; Nagaty, I.M.; Maboud, A.I. 2001: Soluble adhesion molecules versus lymphoblast transformation in diagnosis of zoonotic cutaneous leishmaniasis Journal of the Egyptian Society of Parasitology 31(3): 761
Vladimirova-Kitova, L.G.; Deneva, T.I.; Nikolov, F.P. 2011: Effect of moderate and high dose simvastatin on adhesion molecules in severe hypercholesterolemia after targeting the LDL-cholesterol--a randomised, placebo-controlled study Folia Medica 53(2): 13-21